Exact Mass: 1295.6342

Exact Mass Matches: 1295.6342

Found 17 metabolites which its exact mass value is equals to given mass value 1295.6342, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Angiotensin I

(2S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]-3-(1H-imidazol-5-yl)propanamido]-4-methylpentanoic acid

C62H89N17O14 (1295.6775)

Angiotensin I appears to have no biological activity and exists solely as a precursor to angiotensin 2. Angiotensin I is formed by the action of renin on angiotensinogen. Renin cleaves the peptide bond between the leucine (Leu) and valine (Val) residues on angiotensinogen, creating the ten-amino acid peptide (des-Asp) angiotensin I. Renin is produced in the kidneys in response to renal sympathetic activity, decreased intrarenal blood pressure at the juxtaglomerular cells, or decreased delivery of Na+ and Cl- to the macula densa.[3] If less Na+ is sensed by the macula densa, renin release by juxtaglomerular cells is increased. (Wikipedia) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from WikiPathways, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Angiotensin I (human, mouse, rat) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE).

Avorelin

1-{5-[(diaminomethylidene)amino]-2-(2-{2-[2-(3-hydroxy-2-{2-[3-(1H-imidazol-5-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanamido]-3-(1H-indol-3-yl)propanamido}propanamido)-3-(4-hydroxyphenyl)propanamido]-3-(2-methyl-1H-indol-3-yl)propanamido}-4-methylpentanamido)pentanoyl}-N-ethylpyrrolidine-2-carboxamide

C65H85N17O12 (1295.6563)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Lutrelin

1-{5-carbamimidamido-2-[(2-{2-[(2-{[1,3-dihydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(1H-imidazol-5-yl)propylidene)amino]-3-(1H-indol-3-yl)propylidene}amino)propylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(1H-indol-3-yl)-N-methylpropanamido}-1-hydroxy-4-methylpentylidene)amino]pentanoyl}-N-ethylpyrrolidine-2-carboximidate

C65H85N17O12 (1295.6563)

A ten amino acid peptide formed by renin cleavage of angiotensinogen. Angiotensin I has no direct biological function except that high levels can stimulate catecholamine production. It is metabolized to its biologically active byproduct angiotensin II, a potent vasoconstrictor, by angiotensin converting enzyme (ACE) through cleavage of the two terminal amino acids. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from WikiPathways, COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Angiotensin I (human, mouse, rat) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE).

angiotensin I dizwitterion

C62H89N17O14 (1295.6775)

A peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3.

Human angiotensin I

C62H89N17O14 (1295.6775)

2-(2-{[2-({6-amino-1-hydroxy-2-[(1-hydroxy-2-{[hydroxy(8-hydroxy-5-{[1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-9-oxo-1h,2h,3h,4h-pyrimido[1,2-a]quinolin-1-yl)methylidene]amino}propylidene)amino]hexylidene}amino)-1-hydroxyethylidene]amino}-n-hydroxyacetamido)-n-[3-carbamoyl-1-(4-{[2-hydroxy-1-({1-[(1-methyl-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}-3,4,5,6-tetrahydropyrimidin-2-yl)propyl]butanediimidic acid

2-(2-{[2-({6-amino-1-hydroxy-2-[(1-hydroxy-2-{[hydroxy(8-hydroxy-5-{[1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-9-oxo-1h,2h,3h,4h-pyrimido[1,2-a]quinolin-1-yl)methylidene]amino}propylidene)amino]hexylidene}amino)-1-hydroxyethylidene]amino}-n-hydroxyacetamido)-n-[3-carbamoyl-1-(4-{[2-hydroxy-1-({1-[(1-methyl-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-c-hydroxycarbonimidoyl}-3,4,5,6-tetrahydropyrimidin-2-yl)propyl]butanediimidic acid

C55H81N19O18 (1295.6007)

1-[(2s,3r,4s,5r)-3-hydroxy-4-{[hydroxy([(2r)-1-({1-hydroxy-3-[(1r,2r,3r,4r,8s,13s,14s,18s,19s)-8,13,18-tris(2-carboximidatoethyl)-3,14,19-tris(c-hydroxycarbonimidoylmethyl)-1,4,6,9,9,14,16,19-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1²,⁵.1⁷,¹⁰.1¹²,¹⁵]tricosa-5(23),6,10(22),11,15(21),16-hexaen-4-yl]propylidene}amino)propan-2-yl]oxy)phosphoryl]oxy}-5-(hydroxymethyl)oxolan-2-yl]-5,6-dimethyl-3h-1λ⁵,3-benzodiazol-1-ylium; cyano radical

1-[(2s,3r,4s,5r)-3-hydroxy-4-{[hydroxy([(2r)-1-({1-hydroxy-3-[(1r,2r,3r,4r,8s,13s,14s,18s,19s)-8,13,18-tris(2-carboximidatoethyl)-3,14,19-tris(c-hydroxycarbonimidoylmethyl)-1,4,6,9,9,14,16,19-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1²,⁵.1⁷,¹⁰.1¹²,¹⁵]tricosa-5(23),6,10(22),11,15(21),16-hexaen-4-yl]propylidene}amino)propan-2-yl]oxy)phosphoryl]oxy}-5-(hydroxymethyl)oxolan-2-yl]-5,6-dimethyl-3h-1λ⁵,3-benzodiazol-1-ylium; cyano radical

[C63H88N14O14P]2- (1295.6342)

(2s)-2-{2-[(2-{[(2r)-6-amino-1-hydroxy-2-{[(2r)-1-hydroxy-2-({hydroxy[(1s)-8-hydroxy-5-{[1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-9-oxo-1h,2h,3h,4h-pyrimido[1,2-a]quinolin-1-yl]methylidene}amino)propylidene]amino}hexylidene]amino}-1-hydroxyethylidene)amino]-n-hydroxyacetamido}-n-[(1r)-3-carbamoyl-1-(4-{[(1s)-2-hydroxy-1-{[(1r)-1-{[(3s)-1-methyl-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}-3,4,5,6-tetrahydropyrimidin-2-yl)propyl]butanediimidic acid

(2s)-2-{2-[(2-{[(2r)-6-amino-1-hydroxy-2-{[(2r)-1-hydroxy-2-({hydroxy[(1s)-8-hydroxy-5-{[1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-9-oxo-1h,2h,3h,4h-pyrimido[1,2-a]quinolin-1-yl]methylidene}amino)propylidene]amino}hexylidene]amino}-1-hydroxyethylidene)amino]-n-hydroxyacetamido}-n-[(1r)-3-carbamoyl-1-(4-{[(1s)-2-hydroxy-1-{[(1r)-1-{[(3s)-1-methyl-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}-3,4,5,6-tetrahydropyrimidin-2-yl)propyl]butanediimidic acid

C55H81N19O18 (1295.6007)